Invivyd, Inc. Files 8-K
Ticker: IVVD · Form: 8-K · Filed: Dec 23, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | 8-K |
| Filed Date | Dec 23, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
Related Tickers: IVVD
TL;DR
Invivyd (IVVD) filed a standard 8-K on Dec 23, 2025. No major news, just corporate housekeeping.
AI Summary
Invivyd, Inc. filed an 8-K on December 23, 2025, reporting other events and financial statements. The company, formerly known as Adagio Therapeutics, Inc., is incorporated in Delaware and has its principal executive offices in New Haven, CT. The filing does not detail specific transactions or financial figures but serves as a standard corporate disclosure.
Why It Matters
This filing indicates routine corporate activity and disclosure for Invivyd, Inc., formerly Adagio Therapeutics, Inc., providing transparency to investors regarding its operational status.
Risk Assessment
Risk Level: low — This is a routine 8-K filing with no specific material events or financial disclosures that would inherently increase risk.
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former Name
- December 23, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- New Haven, CT (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Invivyd, Inc.?
This 8-K filing on December 23, 2025, is for reporting 'Other Events' and 'Financial Statements and Exhibits' as per standard SEC requirements.
When was Invivyd, Inc. previously known by another name?
Invivyd, Inc. was formerly known as Adagio Therapeutics, Inc., with a date of name change on November 12, 2020.
Where are Invivyd, Inc.'s principal executive offices located?
Invivyd, Inc.'s principal executive offices are located at 209 Church Street, New Haven, CT 06510.
What is Invivyd, Inc.'s fiscal year end?
Invivyd, Inc.'s fiscal year ends on December 31.
What is the SIC code for Invivyd, Inc.?
Invivyd, Inc. has a Standard Industrial Classification (SIC) code of 2836 for BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES).
Filing Stats: 430 words · 2 min read · ~1 pages · Grade level 11 · Accepted 2025-12-23 07:08:26
Key Financial Figures
- $0.0001 — ch registered Common stock, par value $0.0001 per share IVVD The Nasdaq Stock Mar
Filing Documents
- ivvd-20251223.htm (8-K) — 57KB
- ivvd-ex99_1.htm (EX-99.1) — 22KB
- img59752938_0.jpg (GRAPHIC) — 84KB
- 0001193125-25-329488.txt ( ) — 312KB
- ivvd-20251223.xsd (EX-101.SCH) — 31KB
- ivvd-20251223_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On December 23, 2025, Invivyd, Inc. issued a press release entitled "Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID." A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference in this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release, dated December 23, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. INVIVYD, INC. Date: December 23, 2025 By: /s/ Jill Andersen Jill Andersen Chief Legal Officer and Corporate Secretary